Company Overview of Ambrilia Biopharma, Inc.
Phil Gold M.D., Ph.D., CC, OQ, FRS(C), FRCP(C)
Chairman of Scientific Advisory Board, Ambrilia Biopharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 Board Members in 6 different organizations across 5 different industries.|
See Board Relationships
1010 Sherbrooke StreetPhone: 514-751-2003
Montreal, Quebec H3A 2R7
Board Members Memberships
Chairman of the Board
Chairman of Scientific Advisory Board and Director
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.